Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in ChinaBecotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07697040 - No phaseTaking peopleDigital Rehabilitation for Gastric Cancer Surgery After Neoadjuvant Therapy
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 186
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07441850 - Phase 2Taking peopleChemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer
- Where
- Beijing, Shenzhen, Taiyuan
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07689851 - No phaseTaking peopleMultimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
- Where
- Changsha
- People
- 200
- Run by
- Central South University
See details and how to joinNCT07063901 - Phase 2Taking peopleBecotatug Vedotin ± Anti-PD-1 in Pretreated Advanced ESCC
- Where
- Shanghai
- Age
- 18 years and over
- People
- 104
- Run by
- Fudan University
See details and how to joinNCT07403136 - No phaseEnrolling by invitationResearch on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction
- Where
- Jinan
- Age
- 18 years to 85 years
- People
- 900
- Run by
- Liu Yang
See details and how to joinNCT07683195 - Phase 2Not yet taking people in ChinaA Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07688291 - Phase 2Not yet taking people in ChinaZanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study
- Where
- Xi’an
- Age
- 18 years to 75 years
- People
- 46
- Run by
- Zhifeng Zhao, PhD
See details and how to joinNCT07685704 - Phase 2Not yet taking people in ChinaNeoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 50
- Run by
- Tang-Du Hospital
See details and how to joinNCT07678580 - Phase 3Taking peopleJS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 600
- Run by
- NingBo Junyan Hongshi Biosciences Co., Ltd
See details and how to joinNCT07584135 - No phaseNot yet taking people in ChinaNeoadjuvant PD-1 Inhibitor Plus SOX Chemotherapy With or Without Short-Course Radiotherapy for Locally Advanced Upper Gastric or GEJ Adenocarcinoma
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 146
- Run by
- Tongji Hospital
See details and how to joinNCT07674342 - Phase 3Taking peopleClinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
- Where
- Anyang, Baoji, Beijing, Changchun, Changsha, Changzhi, Changzhou, Chengde, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Guangzhou, Guigang, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Jiamusi, Jinan, Jingzhou, Jining, Kunming, Lanzhou, Linyi, Lishui, Luoyang, Meizhou, Nanchang, Nanchong, Nanjing, Nanning, Nantong, Nanyang, Qingdao, Shanghai, Shantou, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Ürümqi, Weifang, Wenzhou, Wuhan, Wuhu, Wuwei, Xiamen, Xi'an, Xi’an, Xining, Xuzhou, Yangzhou, Yuncheng, Zhengzhou, Zunyi
- Age
- 18 years and over
- People
- 752
- Run by
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT07385703 - Phase 2Not yet taking people in ChinaA Study on the Efficacy and Safety of Sintilimab Combined With Ramucirumab and Paclitaxel in the Treatment of Gastric Cancer Patients With Short-term Recurrence After Adjuvant Therapy
- Where
- Nanjing
- Age
- 15 years to 75 years
- People
- 30
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07669740 - No phaseNot yet taking people in ChinaOne-Click Autofocus Versus Segmented Focus in Gastric Endoscopy
- Where
- Jinan
- Age
- 18 years and over
- People
- 93
- Run by
- Shandong University
See details and how to joinNCT07664813 - Phase 2Not yet taking people in ChinaSintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 27
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06365008 - Phase 2Not yet taking people in ChinaMannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 52
- Run by
- Ming Liu
See details and how to joinNCT07655661 - No phaseNot yet taking people in ChinaNon-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
- Where
- Beijing
- People
- 50
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07656740 - Phase 2Taking peopleTAIC FOLFOX for Locally Advanced G/GEJA
- Where
- Beijing
- Age
- 18 years and over
- People
- 31
- Run by
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT07655024 - No phaseTaking peopleThe Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy
- Where
- Beijing
- Age
- 18 years and over
- People
- 300
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07187154 - No phaseTaking peoplePostoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy
- Where
- Chengdu, Guangzhou, Nanchong, Shanghai, Shantou, Shijiazhuang
- Age
- 18 years to 80 years
- People
- 2,500
- Run by
- Sun Yat-sen University
See details and how to joinNCT07309991 - No phaseTaking peopleTwo-component Radiology-guided Autonomous Cascade Engine (TRACE)
- Where
- Shenyang
- People
- 54
- Run by
- Liaoning Cancer Hospital & Institute
See details and how to joinNCT07651644 - Phase 3Taking peopleTransarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 190
- Run by
- Zhejiang University
See details and how to joinNCT05593458 - Phase 2Taking peopleAdebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Sun Yat-sen University
See details and how to joinNCT07638436 - No phaseTaking peopleClinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
- Where
- Chengdu, Chongqing, Nanjing, Shanghai, Shenyang, Ürümqi, Wuhan, Xi'an, Xi’an
- Age
- 18 years to 75 years
- People
- 96
- Run by
- Tang-Du Hospital
See details and how to joinNCT06128252 - No phaseNot yet taking people in ChinaRecurrence After Gastric and Intestinal Polyp Resection
- Where
- Lanzhou
- Age
- 18 years and over
- People
- 2,000
- Run by
- LanZhou University
See details and how to joinNCT07314554